lenalidomide pharmascience 7,5 mg kapsułki twarde
pharmascience international limited - lenalidomidum - kapsułki twarde - 7,5 mg
lenalidomide pharmascience 25 mg kapsułki twarde
pharmascience international limited - lenalidomidum - kapsułki twarde - 25 mg
lenalidomide pharmascience 2,5 mg kapsułki twarde
pharmascience international limited - lenalidomidum - kapsułki twarde - 2,5 mg
lenalidomide pharmascience 5 mg kapsułki twarde
pharmascience international limited - lenalidomidum - kapsułki twarde - 5 mg
sunitinib msn 50 mg kapsułki twarde
msn labs europe limited - sunitinibum - kapsułki twarde - 50 mg
sunitinib msn 37,5 mg kapsułki twarde
msn labs europe limited - sunitinibum - kapsułki twarde - 37,5 mg
sunitinib msn 25 mg kapsułki twarde
msn labs europe limited - sunitinibum - kapsułki twarde - 25 mg
sunitinib msn 12,5 mg kapsułki twarde
msn labs europe limited - sunitinibum - kapsułki twarde - 12,5 mg
dasatinib accord
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - Środki przeciwnowotworowe - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.
vafseo
akebia europe limited - vadadustat - renal insufficiency, chronic; anemia - preparaty antyanemiczne - vafseo is indicated for the treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.